RAB3GAP2
protein-codingRAB3 GTPase activating non-catalytic protein subunit 2, the group of Small nucleolar RNA protein coding host genes|MicroRNA protein coding host genes
Gene summary
The protein encoded by this gene belongs to the RAB3 protein family, members of which are involved in regulated exocytosis of neurotransmitters and hormones. This protein forms the Rab3 GTPase-activating complex with RAB3GAP1, where it constitutes the regulatory subunit, whereas the latter functions as the catalytic subunit. This gene has the highest level of expression in the brain, consistent with it having a key role in neurodevelopment. Mutations in this gene are associated with Martsolf syndrome.[provided by RefSeq, Oct 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~124.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0700247
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013641
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0008929
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0018421
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0016649
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013641
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:8000008
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0016649
Submitter: ClinGen
RAB3GAP2 was first reported in relation to autosomal recessive Martsolf Syndrome in 2006 (Aligianis et al. PMID 16532399) and autosomal recessive Warburg Micro syndrome in 2011 (Borck et al. PMID 20967465). Martsolf syndrome and Warburg Micro syndrome are clinically overlapping autosomal recessive conditions characterized by congenital cataracts, microphthalmia, microcephaly, hypotonia and neurodevelopmental delay, in which Martsolf syndrome presents with a milder and Warburg Micro syndrome presents with a more severe clinical phenotype. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism or inheritance pattern between these conditions. Therefore, the following disease entities: Martsolf syndrome 1 (OMIM: 212720) and Warburg micro syndrome 2 (OMIM: 614225) have been lumped into one disease entity in this curation. Eighteen variants (4 missense, 1 in-frame indel, 10 nonsense, 2 frameshift, 1 splice site) that have been reported in 8 Martsolf and 10 Warburg Micro probands in 5 publications (PMIDs: 16532399, 20967465, 23420520, 32740904, 32376645) are included in this curation; the maximum score for genetic evidence (12 pts) has been reached. The mechanism of pathogenicity appears to be loss of function. This gene-disease association is also supported by biochemical function assays (PMIDs 24891604). In summary, RAB3GAP2 is definitively associated with autosomal recessive Warburg micro spectrum, a disease entity that includes both Martsolf syndrome (OMIM: 212720) and Warburg micro syndrome (OMIM: 614225). This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the Brain Malformations GCEP on November 28, 2023.
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Endocrine; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Endocrine; Ophthalmologic; Pharmacogenomic
Rationale: The condition can include a risk of glaucoma, and early treatment may be beneficial; Medical care related to endocrine manifestations may be indicated; Agents that may contribute to glaucoma should be avoided
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RAB3GAP2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_012414.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 10 | 152 | 1 | 163 | ||
| missense | 1 | 4 | 340 | 23 | 3 | 371 |
| nonsense | 7 | 8 | 2 | 17 | ||
| start loss | 1 | 1 | ||||
| frameshift | 9 | 10 | 2 | 21 | ||
| splice donor/acceptor (+/-2bp) | 2 | 12 | 13 | 27 | ||
| Total | 19 | 34 | 368 | 175 | 4 | 600 |
Highest pathogenic variant AF is 0.000011153397
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_036546.2 | 35 | MANE Select | |
| Ensembl | ENSP00000351832.2 | 35 | MANE Select | |
| Ensembl | ENSP00000420156.1 | 4 | Standard | |
| Ensembl | ENSP00000509457.1 | 24 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Vesicle-mediated transport
- Membrane Trafficking
- Effects of Botulinum toxin
- Rab regulation of trafficking
- COPI-independent Golgi-to-ER retrograde traffic
Biological Process
- intracellular protein transport
- regulation of GTPase activity
- positive regulation of GTPase activity
- establishment of protein localization to endoplasmic reticulum membrane
- positive regulation of protein lipidation
Molecular Function
- GTPase activator activity
- protein binding
- enzyme activator activity
- Rab guanyl-nucleotide exchange factor activity
- Rab GTPase binding
Cellular Component
- endoplasmic reticulum membrane
- cytosol
- plasma membrane
- protein-containing complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000358951
- Coding exons
- 35
- Length
- 124162
- Individuals with no LoFs
- 125708
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 40
- Defined
- 125748
- p
- 0.000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.868 | 645 | 710 | 0.908 | 0.0000352 | 9119 |
| Missense (PolyPhen) | 158 | 222.27 | 0.71086 | 2812 | ||
| Synonymous | 1.05 | 238 | 259 | 0.917 | 0.0000134 | 2637 |
| Loss of Function | 6.85 | 16 | 83.6 | 0.191 | 0.00000426 | 987 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.00012 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00011 | 0.000099 | rare |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00018 | 0.00018 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00018 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Regulatory subunit of a GTPase activating protein that has specificity for Rab3 subfamily (RAB3A, RAB3B, RAB3C and RAB3D). Rab3 proteins are involved in regulated exocytosis of neurotransmitters and hormones. Rab3 GTPase-activating complex specifically converts active Rab3-GTP to the inactive form Rab3- GDP. Required for normal eye and brain development. May participate in neurodevelopmental processes such as proliferation, migration and differentiation before synapse formation, and non- synaptic vesicular release of neurotransmitters. {ECO:0000269|PubMed:9733780}.;
- Disease
- DISEASE: Warburg micro syndrome 2 (WARBM2) [MIM:614225]: A rare syndrome characterized by microcephaly, microphthalmia, microcornia, congenital cataracts, optic atrophy, cortical dysplasia, in particular corpus callosum hypoplasia, severe mental retardation, spastic diplegia, and hypogonadism. {ECO:0000269|PubMed:20967465}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- LoFtool
- 0.420
- RVIS EVS
- -1.08
- RVIS percentile EVS
- 7.28
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.919
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |